Behavioral Activation Plus Savoring for University Students

February 15, 2022 updated by: Southern Methodist University

A Randomized Controlled Trial of Behavioral Activation Plus Savoring for University Students With Positive Valence Dysregulation

The current investigation aims to examine whether a brief, two-session, virtual behavioral activation plus savoring intervention will increase daily positive emotion in university students.

Study Overview

Detailed Description

Experiences of positive emotions are often unchanged following standard psychotherapy. To address this, the current investigation aims to enhance traditional brief behavioral activation with savoring, an emotion regulation strategy specifically targeting positive emotion, or affect, for university students endorsing low levels of the symptom. Individuals will be randomized to either a two-session behavioral activation plus savoring intervention or two sessions of empathic listening. Daily levels of positive emotions will be assessed throughout the study and for one week prior to and completing the intervention.

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Divya Kumar, M.A.
  • Phone Number: 2147681767
  • Email: divyak@smu.edu

Study Locations

    • Texas
      • Dallas, Texas, United States, 75206
        • Recruiting
        • Southern Methodist University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • University student
  • Own a smartphone
  • Positive affect score less than 32 on the Positive and Negative Affect Schedule, Short Form (PANAS-SF)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Behavioral Activation plus Savoring
Individuals in this intervention will complete two sessions of behavioral activation, where they will be provided psychoeducation on behavioral models of mood, schedule activities, and discuss barriers to completion. Additionally, they will practice savoring as a cognitive strategy to increase positive emotions with a study therapist.
Individuals in this intervention will complete two sessions of behavioral activation, where they will be provided psychoeducation on behavioral models of mood, schedule activities, and discuss barriers to completion. Additionally, they will practice savoring as a cognitive strategy to increase positive emotions with a study therapist.
Active Comparator: Empathic Listening
Individuals in the active control condition will complete two sessions of reflecting on tracking their mood and empathic listening with a study therapist.
Individuals in the active control condition will complete two sessions of reflecting on tracking their mood and empathic listening with a study therapist.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Positive Emotions: Modified Differential Emotions Scale (mDES; Fredrickson et al., 2003)
Time Frame: Change from first session to post-treatment (14 days)
Positive mood, as measured by the mDES, will be collected two times a day. Participants will be asked to rate their level of positive mood in the moment. Positive mood will be collected on a daily basis throughout the study and change in reported positive emotions will be assessed.
Change from first session to post-treatment (14 days)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Positive and Negative Affect Schedule (PANAS)
Time Frame: Change from baseline to post-treatment (21 days)
Change in reported symptoms of positive and negative affect following the intervention
Change from baseline to post-treatment (21 days)
Depression, Anxiety, and Stress Scale (DASS-21)
Time Frame: Change from baseline to post-treatment (21 days)
Change in self-reported symptoms of depression, anxiety, and stress following the intervention
Change from baseline to post-treatment (21 days)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 6, 2021

Primary Completion (Anticipated)

June 1, 2022

Study Completion (Anticipated)

June 1, 2022

Study Registration Dates

First Submitted

October 8, 2021

First Submitted That Met QC Criteria

February 1, 2022

First Posted (Actual)

February 10, 2022

Study Record Updates

Last Update Posted (Actual)

February 16, 2022

Last Update Submitted That Met QC Criteria

February 15, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 21-118

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Behavioral Activation plus Savoring

3
Subscribe